Page last updated: 2024-11-02
piribedil and Cognitive Decline
piribedil has been researched along with Cognitive Decline in 1 studies
Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "More people are presenting with mild cognitive impairment (MCI), frequently a precursor to dementia, but we do not know how to reduce deterioration." | 2.49 | Treatment for mild cognitive impairment: systematic review. ( Cooper, C; Li, R; Livingston, G; Lyketsos, C, 2013) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Cooper, C | 1 |
| Li, R | 1 |
| Lyketsos, C | 1 |
| Livingston, G | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Efficacy of a 24-week Long Term Transcranial Pulse Stimulation (TPS) on Cognition and Brain Structure in Older Adults With Mild Neurocognitive Disorder (NCD)[NCT05602467] | | 22 participants (Anticipated) | Interventional | 2022-11-25 | Recruiting |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Reviews
1 review available for piribedil and Cognitive Decline